Neuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus Spread
Open Access
- 15 June 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (12) , 6172-6184
- https://doi.org/10.1128/jvi.76.12.6172-6184.2002
Abstract
Serial passage of yellow fever 17D virus (YF5.2iv, derived from an infectious molecular clone) on mouse neuroblastoma (NB41A3) cells established a persistent noncytopathic infection associated with a variant virus. This virus (NB15a) was dramatically reduced in plaque formation and exhibited impaired replication kinetics on all cell lines examined compared to the parental virus. Nucleotide sequence analysis of NB15a revealed a substitution in domain III of the envelope (E) protein at residue 360, where an aspartic acid residue was replaced by glycine. Single mutations were also found within the NS2A and NS3 proteins. Engineering of YF5.2iv virus to contain the E 360 substitution yielded a virus (G360 mutant) whose plaque size and growth efficiency in cell culture resembled those of NB15a. Compared with YF5.2iv, both NB15a and G360 were markedly restricted for spread through Vero cell monolayers and mildly restricted in C6/36 cells. On NB41A3 cells, spread of the viruses was similar, but all three were generally inefficient compared with spread in other cell lines. Compared to YF5.2iv virus, NB15a was uniformly impaired in its ability to penetrate different cell lines, but a difference in cell surface binding was detected only on NB41A3 cells, where NB15a appeared less efficient. Despite its small plaque size, impaired growth, and decreased penetration efficiency, NB15a did not differ from YF5.2iv in mouse neurovirulence testing, based on mortality rates and average survival times after intracerebral inoculation of young adult mice. The data indicate that persistence of yellow fever virus in NB41A3 cells is associated with a mutation in the receptor binding domain of the E protein that impairs the virus entry process in cell culture. However, the phenotypic changes which occur in the virus as a result of the persistent infection in vitro do not correlate with attenuation during pathogenesis in the mouse central nervous system.Keywords
This publication has 43 references indexed in Scilit:
- Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In VivoJournal of Virology, 2001
- Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of HepatocytesHepatology, 2000
- A Mouse-attenuated Envelope Protein Variant of Murray Valley Encephalitis Virus with Altered Fusion ActivityJournal of General Virology, 1996
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Persistent infection of Vero cells by the flavivirus Murray Valley encephalitis virusJournal of General Virology, 1991
- Characterization of Antigenic Variants of Tick-borne Encephalitis Virus Selected with Neutralizing Monoclonal AntibodiesJournal of General Virology, 1989
- Establishment and Characterization of St Louis Encephalitis Virus Persistent Infections in Aedes and Culex Mosquito Cell LinesJournal of General Virology, 1988
- Phenotypes of St Louis Encephalitis Virus Mutants Produced in Persistently Infected Mosquito Cell CulturesJournal of General Virology, 1988
- Characteristics of Aedes albopictus cells persistently infected with dengue virusesNature, 1979